Gritstone, Gilead Partner To Develop Therapeutic HIV Vaccine

Deal Closely Follows COVID-19 Vaccine Effort

 
• By Alaric DeArment
HIV Vaccine
Gritstone and Gilead are partnering to develop a therapeutic HIV vaccine. • Source: Shutterstock

More from R&D

More from Scrip